These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23575064)

  • 21. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
    Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
    Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An introduction to molecular pathology of the head and neck.
    Hunt JL
    Arch Pathol Lab Med; 2014 Jun; 138(6):730. PubMed ID: 24878012
    [No Abstract]   [Full Text] [Related]  

  • 23. Tumor markers of head and neck carcinoma.
    Eibling DE; Wagner RL; Johnson JT
    Immunol Ser; 1990; 53():357-83. PubMed ID: 2100567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RCAS-1 serum and tumor levels in head and neck squamous cell carcinoma.
    Brunner M; Erovic B; Heiduschka G; Schneider S; Pammer J; Frantal S; Thurnher D
    Eur Surg Res; 2010; 44(3-4):214-9. PubMed ID: 20571277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of MAGE A 1-6 mRNA in sputa of head and neck cancer patients--a preliminary report.
    Lee KD; Lee HH; Joo HB; Lee HS; Yu TH; Chang HK; Jeon CH; Park JW
    Anticancer Res; 2006; 26(2B):1513-8. PubMed ID: 16619566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of biomarkers in head and neck squamous cell carcinoma.
    Tse GM; King AD; Yu AM; Lam CC; Chan AW; Chen GG; Yeung DK; Yu KH; Bhatia KS; Chan AB
    Otolaryngol Head Neck Surg; 2010 Dec; 143(6):795-800. PubMed ID: 21109080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can molecular markers predict local, regional and distant metastasis in head and neck cancer?
    Haffty BG
    Nat Clin Pract Oncol; 2005 Mar; 2(3):132-3. PubMed ID: 16264904
    [No Abstract]   [Full Text] [Related]  

  • 28. Body fluid biomarkers for early detection of head and neck squamous cell carcinomas.
    Lee KD; Lee HS; Jeon CH
    Anticancer Res; 2011 Apr; 31(4):1161-7. PubMed ID: 21508360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioinformatics in otolaryngology.
    Imani F
    Otolaryngol Clin North Am; 2005 Apr; 38(2):321-32, vii. PubMed ID: 15823596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic factors associated with head and neck cancer.
    Br Dent J; 2007 Jan; 202(2):58. PubMed ID: 17255975
    [No Abstract]   [Full Text] [Related]  

  • 31. A disturbance in the force--mitochondrial mutations in squamous cell carcinoma of the head and neck.
    Cohen EE
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4317-9. PubMed ID: 17671110
    [No Abstract]   [Full Text] [Related]  

  • 32. Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers.
    Boldrup L; Coates PJ; Hedberg Y; Sjöström B; Dahlqvist A; Nylander K
    Int J Oncol; 2005 Dec; 27(6):1661-7. PubMed ID: 16273222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation.
    Yang MH; Chiang WC; Chou TY; Chang SY; Chen PM; Teng SC; Wu KJ
    Clin Cancer Res; 2006 Jan; 12(2):507-15. PubMed ID: 16428493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LHX6 is a sensitive methylation marker in head and neck carcinomas.
    Estécio MR; Youssef EM; Rahal P; Fukuyama EE; Góis-Filho JF; Maniglia JV; Goloni-Bertollo EM; Issa JP; Tajara EH
    Oncogene; 2006 Aug; 25(36):5018-26. PubMed ID: 16732332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolving 'omics' technologies for diagnostics of head and neck cancer.
    Nagaraj NS
    Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
    Rosas SL; Koch W; da Costa Carvalho MG; Wu L; Califano J; Westra W; Jen J; Sidransky D
    Cancer Res; 2001 Feb; 61(3):939-42. PubMed ID: 11221887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular pathogenesis of head and neck cancers.
    Singh B
    J Surg Oncol; 2008 Jun; 97(8):634-9. PubMed ID: 18493941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
    Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
    Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.
    Eibling DE; Johnson JT; Wagner RL; Su S
    Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.